secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2022-08-31T23:59:59+00:00
Accession:  0001628280-22-024056
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn co-founder Cigall Kadoch resigns from board after HHMI appointment; stays as scientific advisor
--------------------------------------------------------------------------------

- Cigall Kadoch resigned from Foghorn's Board of Directors effective August 31, 2022.
- Resignation due to her appointment as HHMI Investigator; no disagreement with the company.
- Kadoch transitions to role of Scientific Advisor to the Board and remains on Scientific Advisory Board.
- Co-founder and former board member will continue to advise the company on chromatin regulatory system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828022024056/0001628280-22-024056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828022024056/fhtx-20220831.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-024056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer